| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing sofosbuvir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing ledipasvir and sofosbuvir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing sofosbuvir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing simeprevir and sofosbuvir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
2 |
| Product containing sofosbuvir and velpatasvir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing sofosbuvir and velpatasvir and voxilaprevir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing sofosbuvir and velpatasvir and voxilaprevir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Sofosbuvir- and velpatasvir-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Ledipasvir and sofosbuvir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing only simeprevir and sofosbuvir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
2 |
| Sofosbuvir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing only sofosbuvir and velpatasvir and voxilaprevir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing only sofosbuvir and velpatasvir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing only sofosbuvir and velpatasvir and voxilaprevir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Sofosbuvir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Sofosbuvir and velpatasvir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sofosbuvir (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]